TRT(SH:600085) Zhong Guo Jing Ying Bao·2025-12-17 15:16Group 1 - The core issue involves a false labeling incident related to a product marketed as "Beijing Tongrentang 99% High Purity Antarctic Krill Oil," which was found to have a phospholipid content of 0% despite claims of high quality [3][4] - Beijing Tongrentang Co., Ltd. clarified that the implicated company, Beijing Tongrentang (Sichuan) Health Pharmaceutical Co., Ltd., is not a subsidiary of theirs, but rather a subsidiary of Beijing Tongrentang Health Pharmaceutical Co., Ltd., which is part of the Tongrentang Group [3] - The company emphasized its commitment to protecting consumer rights and its brand image, stating that all its medicines are produced in-house without outsourcing to third parties [3] Group 2 - The Shanghai Consumer Protection Commission announced plans to interview the involved companies due to the allegations of product falsification [4] - The product in question was produced by Anhui Habao Pharmaceutical Co., Ltd. and distributed by Beijing Tongrentang (Sichuan) Health Pharmaceutical Co., Ltd. [4] - As of December 17, the total market capitalization of Beijing Tongrentang was approximately 44.67 billion yuan [3]